Jill Feldman
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Jill Feldman
Oct 16, 2024, 14:21 |
Blog
Jill Feldman on creating a patient-friendly lung cancer lexicon
Jill Feldman shared a post by Oncogene Cancer Research on X, adding: "Here I discuss my presentation AT…
Oct 15, 2024, 17:29 |
Blog
Jill Feldman: Interesting finding for people with EFGR lung cancer that transforms to SCLC
Jill Feldman shared a post on X by Stephen V Liu adding: "Very interesting finding…
Oct 14, 2024, 14:39 |
Blog
Oncoinfluencers to Follow on Social Media: Jill Feldman
We are excited to introduce Jill Feldman, a dedicated lung cancer patient advocate, as our…
Oct 9, 2024, 15:23 |
Blog
Upal Basu Roy: How immune cells can be engineered to target EGFR+ NSCLC
Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, shared about a Facebook Live…
Oct 1, 2024, 03:39 |
Blog
Jill Feldman: The need for accessible, patient-friendly language in treatment discussions
Jill Feldman shared on X: "This study by Stephanie Graff and team (MUST READ for…
Sep 27, 2024, 18:25 |
Blog
Stacey Tinianov: Our poster Advocacy-led co-creation and accrual of a pan-cancer QoL survey at ASCOQLTY24
Stacey Tinianov shared a post on LinkedIn: "If you're headed to ASCOQLTY24, please check out…
Sep 27, 2024, 14:59 |
Blog
Sébastien Couraud: Alexis Cortot about air pollutants interactions with lung cancers molecular alerations
Jill Feldman shared a post by Sébastien Couraud, Professor of Pulmonology, Université Lyon, on X, adding:…
Sep 21, 2024, 01:31 |
Insight
Jill Feldman: Excited to participate in the 4th Annual End Lung Cancer Now Gathering
Jill Feldman posted on X: “I am excited to participate in the 4th Annual End…
Sep 14, 2024, 15:05 |
Blog
Jill Feldman: The most patient-centered care I’ve seen
Jill Feldman posted on X: "For my presentation at WCLC24, I shared my friend JJ’s…
Sep 14, 2024, 07:16 |
Blog
Using patient friendly language to communicate science empowers patients and families to participate in SDM
Jill Feldman, Co-Founder EGFR Resisters, shared a post on X: "Communication isn’t something doctors learn…
Sep 14, 2024, 06:41 |
Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 13, 2024, 09:31 |
Insight
WCLC24 Highlights by Oncology Brothers
Oncology Brothers shared on X: "WCLC24 Highlights Community Oncology: HARMONi2 in mNSCLC CM77TvsCM816 resectable NSCLC…
Sep 10, 2024, 14:23 |
Blog
Jill Feldman: Fantastic IASLC STARS Scholars get-together
Jill Feldman shared a post on X: ''Fantastic IASLC STARS Scholars get-together! We ate, drank,…
Sep 8, 2024, 13:51 |
Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Aug 30, 2024, 17:13 |
Blog
Jill Feldman: Submit your abstract for the EGFR Resisters Research Summit
EGFR Resisters Research Summit shared a post on X: ''Have you submitted your abstract for…
Aug 24, 2024, 11:15 |
Insight
Jill Feldman: Exciting news for the EGFR lung cancer community
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Jill Feldman on…
Aug 17, 2024, 12:26 |
Blog
Amy C. Moore: Honored to co-chair a session on "Global Aspects of Patient Care" at IASLC's WCLC24
Amy C. Moore shared on LinkedIn: "I am also honored to be co-chairing a session…
Aug 11, 2024, 05:12 |
Insight
Jill Feldman: The future of lung cancer screening (early detection) is bright
Jill Feldman shared on X: "The future of lung cancer screening (early detection) is bright.…
Aug 4, 2024, 11:56 |
Insight
Ivy Riano: designing better trials at AACR, ASCO Methods of Clinical Cancer Research Workshop
Ivy Riano shared a post on X: “A big THANK YOU to our wonderful group…
Jul 27, 2024, 14:08 |
Insight
EGFR Resisters has teamed up with 23andMe on the Lung Cancer Genetics Study
Jill Feldman shared a post by EGFR Resisters on X, adding: “I am grateful for all…
Jul 16, 2024, 23:38 |
Blog
For Caleb Egwuenu best patient advocacy is about adapting to the local needs
Oncogene Cancer Research shared a post on LinkedIn: ''How can we use the best patient…
Jul 5, 2024, 13:40 |
Blog
Amy C. Moore: It's hard to even conceive of an advocacy world without Ivy Elkins
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post…
Jul 5, 2024, 05:47 |
Blog
Jill Feldman: I've lost a masssive piece of my heart with the loss of Ivy
Jill Feldman shared on X: "I've been steering clear of social media this past week as…
Jun 24, 2024, 02:03 |
Opinion
Jill Feldman: We need a shift in the Adverse Event grading system
Jill Feldman shared a post on X: “Just thinking, I strongly advocate changing the dose…
Jun 21, 2024, 10:58 |
Blog
Learning from the legends of lung cancer advocacy with Jill Feldman and Dusty Donaldson - Oncogene Cancer Research
Oncogene Cancer Research shared on LinkedIn: "Whether you're getting started in lung cancer patient advocacy or…
Jun 20, 2024, 15:51 |
Insight
Jill Feldman: Must-read about the burdens and barriers patients face
Jill Feldman shared a post by Nathan Pennell, Vice Chair of Clinical Research at Cleveland Clinic…
Jun 19, 2024, 12:28 |
Blog
Jill Feldman: Thank you Mara Antonoff for truly being patient-centered
Jill Feldman shared a post by Jonathan Spicer, Associate Professor of Surgery at McGill University, on…
Jun 18, 2024, 13:33 |
Blog
Jill Feldman: Inclusion rate of QOL metrics and PROs in clinical trials
Jill Feldman, Co-Founder of EGFR Resisters, shared a post by Mara Antonoff, Associate Professor Thoracic and Cardiovascular…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 7, 2024, 14:32 |
Blog
Jill Feldman: Lay summaries on some of the top research presented at ASCO24
Jill Feldman shared on X/Twitter: "Here are lay summaries on some of the top research presented…
Jun 6, 2024, 10:08 |
Societies
Annabelle Gurwitch: ASCO Patient Award this year goes to the amazing Jill Feldman
Annabelle Gurwitch recently shared a post on X: "Holding each other close. The ASCO Patient…
Jun 2, 2024, 22:09 |
Opinion
Allison Rosen: Well deserved award for Jill Feldman at ASCO24
Allison Rosen, Director of Project ECHO, shared a post by Stacey Tinianov on X/Twitter: "Well deserved…
Jun 2, 2024, 13:07 |
Blog
Jill Feldman: As we anxiously await data to read out at ASCO24, please remember, People Come First!
Jill Feldman shared a post on X/Twitter: ''As we anxiously await data to read out…
Jun 1, 2024, 12:22 |
Blog
Annabelle Gurwitch: Thanks ASCO for granting me a patient advocate scholarship
Annabelle Gurwitch shared a post by Charu Aggarwal, Leslye M. Heisler Associate Professor of Lung…
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 24, 2024, 13:24 |
Blog
Jill Feldman: This is a fantastic resource created by Ambreen Sayani and members of EMPaCT to address power inequities
Jill Feldman shared a post by Ambreen Sayani, Scientist at Women's College Hospital, on LinkedIn,…
May 9, 2024, 14:30 |
Blog
Jill Feldman: Dosing studies are critical!
Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X: "Dosing studies are critical! OS…
May 6, 2024, 08:22 |
Positive
Jill Feldman: We've been talking the talk, but Narjust Florez is walking the walk!
Jill Feldman shared a post by Florez Lab on X: "We've been talking the talk,…
Apr 15, 2024, 13:05 |
Blog
Jill Feldman: A must-attend educational session at ASCO24
Jill Feldman shared a post on X: "Words couldn't be more true - In the era…
Mar 25, 2024, 12:26 |
Blog
Jill Feldman: It is a tremendous honor for the EGFR Resisters to be nominated for the Healio HemOnc Today Patient Voice award among these esteemed organizations
Jill Feldman, Co-Founder of EGFR Resisters, shared a post by Healio on LinkedIn, adding: "It…
Mar 25, 2024, 06:08 |
Career
Jill Feldman: To say I am and deeply honored to receive ASCO Patient Advocate Award is an understatement!
Jill Feldman recently shared a post by ASCO on X, adding: "To say I am deeply…
Mar 24, 2024, 13:03 |
Career
Jill Feldman Awarded the 2024 ASCO Patient Advocate Award
The American Society of Clinical Oncology (ASCO) has announced Jill Feldman, as the recipient of the 2024 ASCO…
Mar 21, 2024, 17:54 |
Career
ASCO announces the recipients of 2024 Special Awards
ASCO shared on their X page: "Along with Conquer Cancer Foundation, we congratulate the recipients…
Mar 8, 2024, 20:11 |
Blog
Ramy Sedhom: The new ASCO guideline represents amazing advances for pts with NSCLC and driver alterations
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, shared a post on…
Mar 4, 2024, 17:34 |
Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Feb 13, 2024, 18:54 |
Opinion
Jill Feldman: It's the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means
Jill Feldman shared Fumiko Ladd Chino's post on X/Twitter, adding: "It's the era of patient-centered ‘everything’…
Feb 10, 2024, 19:00 |
Insight
Jill Feldman: We must try to be ‘precise’ with dosing so people can LIVE better
Jill Feldman shared on X/Twitter: "Thank you, Associated Press for this story on dosing! No…
Feb 8, 2024, 17:06 |
Insight
Narjust Florez: Sexual health in lung cancer made it to the front page of ACS Journal Cancer!
Narjust Florez shared a post by ACS Journal Cancer, on X: A "Grandma! Sexual health…
Feb 1, 2024, 22:57 |
Blog
Jill Feldman: In what universe is 4 - 6 loose stools a day considered tolerable???
Jill Feldman recently shared a post by Stacey Tinianov, Vice President of Patient Advocacy and Engagement…
Jan 30, 2024, 16:49 |
Blog
Stacey Tinianov: The reality of 'manageable and tolerable' side effects as well as risk reduction and management
Stacey Tinianov, Vice President of Patient Advocacy and Engagement at Rabble Health, shared a post by…
Jan 26, 2024, 18:13 |
Blog
Jill Feldman: This picture is worth a thousand words!
Jill Feldman recently shared a post on her LinkedIn page: "This picture is worth a…
Jan 18, 2024, 16:02 |
Blog
Join a MASCC webinar on GI Toxicities from Cancer Therapies
The Multinational Association of Supportive Care in Cancer (MASCC) shared on LinkedIn: "Join us on…
Jan 9, 2024, 18:51 |
Blog
Drew Moganaki about smoking cessation
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Dec 17, 2023, 23:50 |
Blog
Rami Manochakian: Thank You Oncology Brothers for putting together important Cancer Education sessions for the Oncology community
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared the following post by Oncology…
Oct 10, 2023, 15:47 |
Opinion
Jill Feldman: The true art of oncology is understanding that the right approach/treatment MUST align with the soul, preferences and dreams of the patient (and fam) in front of you.
Sep 27, 2023, 22:10 |
Blog
Jill Feldman: Has a patient ever asked you, "What about my kids?"
Jill Feldman, Lung Cancer Patient and Advocate and Co-Founder of EGFR Resisters, made the following…
Sep 23, 2023, 19:24 |
Blog
Jill Feldman: The emotional effects of being told you have a terminal illness, but should be excited/grateful treatment may keep you alive for 3 yrs isn't even recognized!
Sep 23, 2023, 15:55 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
A month ago, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion…
Aug 3, 2023, 19:24 |
Blog
Top 10 World Lung Cancer Day Tweets you shouldn't miss
On World Lung Cancer Day, which falls on August 1, OncoDaily selected 10 important tweets…
Aug 2, 2023, 20:47 |
Blog
A user-friendly, easy-to-navigate, patient-friendly language (lay language often isn't) app is the Holy Grail for our community - Jill Feldman
The most experienced patients & advocates struggle to search for clinical trial, even on http://clinicaltrials.gov.…
All:
60
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube